אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - tetanus toxoid, quantity: 20 lfu/ml; poliovirus, quantity: 80 agu/ml; pertussis filamentous haemagglutinin, quantity: 50 microgram/ml; poliovirus, quantity: 16 agu/ml; pertactin, quantity: 16 microgram/ml; poliovirus, quantity: 64 agu/ml; pertussis toxoid, quantity: 50 microgram/ml; diphtheria toxoid, quantity: 50 lfu/ml - injection, solution - excipient ingredients: aluminium hydroxide hydrate; water for injections; neomycin sulfate; polymyxin b sulfate; sodium chloride; glucose monohydrate; ascorbic acid; polysorbate 80; calcium chloride dihydrate; ferric nitrate nonahydrate; potassium chloride; magnesium sulfate heptahydrate; monobasic potassium phosphate; dibasic sodium phosphate; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine phosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride monohydrate; sodium hypoxanthine; ribose; sodium acetate; thymine; uracil; sodium xanthine; dl-alanine; arginine hydrochloride; dl-aspartic acid; cysteine hydrochloride; cystine dihydrochloride; dl-glutamic acid; glutamine; glycine; histidine hydrochloride; isoleucine; hydroxyproline; dl-leucine; lysine hydrochloride; dl-methionine; dl-phenylalanine; proline; dl-serine; dl-threonine; dl-tryptophan; tyrosine disodium; dl-valine; biotin; ergocalciferol; calcium pantothenate; choline chloride; folic acid; inositol; menadione; nicotinic acid; nicotinamide; aminobenzoic acid; pyridoxal hydrochloride; pyridoxine hydrochloride; riboflavine; thiamine hydrochloride; retinol acetate; dl-alpha-tocopheryl phosphate disodium - 1. infanrix-ipv is indicated for use in a three dose primary schedule for immunisation of infants from 6 weeks of age and over, against diphtheria, tetanus, pertussis and poliomyelitis. infanrix-ipv is also indicated as a single booster dose for children, up to and including 6 years of age, who have previously been immunised against diphthereia, tetanus, pertussis and polio.

דרום אפריקה - אנגלית - South African Health Products Regulatory Authority (SAHPRA)

fresenius kabi south africa (pty) ltd - infusion (parenteral) - see ingredients - each 1 litre of solution contains alanine levo, 7,16 g arginine 6,4 g cysteine 0,38 g glycine 4,14 g histidine 4,14 g isoleucine 6,4 g l-leucine levo, 10,75 g l-lysine 7,09 g l-methionine 4,62 g l-phen

מצרים - אנגלית - EDA (Egyptian Drug Authority)

fresenius kabi-scientific office - infusion - 6 %

מלטה - אנגלית - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - methotrexate - solution for infusion or injection - methotrexate 25 mg - antineoplastic agents

מלטה - אנגלית - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - methotrexate - solution for infusion or injection - methotrexate 25 mg - antineoplastic agents

מלטה - אנגלית - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - methotrexate - solution for infusion or injection - methotrexate 25 mg - antineoplastic agents

מלטה - אנגלית - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - methotrexate - solution for infusion or injection - methotrexate 25 mg/ml - antineoplastic agents

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - sulfamethoxazole; trimethoprim - solution for infusion - 80mg/1ml ; 16mg/1ml

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

sintetica ltd - bupivacaine hydrochloride; fentanyl citrate - solution for infusion - 1.25mg/1ml ; 2microgram/1ml

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

sintetica ltd - fentanyl citrate; bupivacaine hydrochloride - solution for infusion - 2microgram/1ml ; 1.25mg/1ml